Postmortem diagnosis of very long chain acyl‐CoA dehydrogenase (VLCAD) deficiency in a neonate with sudden cardiac death
Abstract Very long chain acyl‐CoA dehydrogenase (VLCAD) deficiency is an autosomal recessive long chain fatty acid β‐oxidation disorder with a variable clinical spectrum, ranging from an acute neonatal presentation with cardiac and hepatic failure to childhood or adult onset of symptoms with hepatom...
Main Authors: | Prapti Singh, Deirdre Amaro, Olugbemisola Obi, FNU Kiran, Erin Hediger, Tomi L. Toler, Patricia I. Dickson, Dorothy K. Grange |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-07-01
|
Series: | JIMD Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/jmd2.12365 |
Similar Items
-
Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular Bioenergetics
by: Olivia M. D’Annibale, et al.
Published: (2022-08-01) -
Metabolic Outcomes of Anaplerotic Dodecanedioic Acid Supplementation in Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficient Fibroblasts
by: Igor Radzikh, et al.
Published: (2021-08-01) -
Biochemical and molecular characteristics among infants with abnormal newborn screen for very-long-chain acyl-CoA dehydrogenase deficiency: A single center experience
by: Jariya Upadia, et al.
Published: (2023-12-01) -
Compartmentalised acyl-CoA metabolism and roles in chromatin regulation
by: Sophie Trefely, et al.
Published: (2020-08-01) -
Triheptanoin: long-term effects in the very long-chain acyl-CoA dehydrogenase-deficient mouse
by: Sara Tucci, et al.
Published: (2017-01-01)